A detailed history of Willner & Heller, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Willner & Heller, LLC holds 1,074 shares of VRTX stock, worth $539,631. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,074
Previous 954 12.58%
Holding current value
$539,631
Previous $447,000 11.63%
% of portfolio
0.46%
Previous 0.44%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$460.0 - $505.78 $55,200 - $60,693
120 Added 12.58%
1,074 $499,000
Q1 2024

Jul 19, 2024

SELL
$407.69 - $446.08 $18,346 - $20,073
-45 Reduced 4.5%
954 $398,000
Q4 2023

Mar 06, 2024

BUY
$343.0 - $410.68 $4,802 - $5,749
14 Added 1.42%
999 $406,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $4,857 - $5,465
-17 Reduced 1.7%
985 $284,000
Q2 2022

Jul 22, 2022

SELL
$234.96 - $292.55 $29,604 - $36,861
-126 Reduced 11.17%
1,002 $282,000
Q1 2022

Jul 05, 2022

SELL
$221.42 - $260.97 $128,423 - $151,362
-580 Reduced 33.96%
1,128 $248,000
Q4 2021

Jun 06, 2022

BUY
$177.01 - $223.45 $302,333 - $381,652
1,708 New
1,708 $310,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Willner & Heller, LLC Portfolio

Follow Willner & Heller, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willner & Heller, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Willner & Heller, LLC with notifications on news.